Sabinsa Secures Psoriasis Patent

Nov 6th, 2008

Katie Schaefer

Sabinsa has secured a patent from the Republic of South Africa for its treatment of psoriasis. The patent, 2007/0694, titled "Compositions and Methods for the Management of Hyperproliferative Dermatological Conditions," describes the composition and its method of use in treating psoriasis.

According to the company, unlike many drugs available for psoriasis, it's treatment did not show any side effects in clinical trials. For more information, visit www.sabinsa.com.

Discover your skin’s mindfulness coach that improves your self-perception

Discover your skin’s mindfulness coach that improves your self-perception

Calisensix™ is an ingredient obtained from the bark of white willow and the stem cells from tomato. It resolves neurogenic inflammation, soothes discomfort and enhances pleasant sensations in sensitive skin, both self-perceived and objectively detected.

Allies of Skin is currently available in 36 countries across 40 retail partners.

Meaningful Partners Invests in Allies of Skin to Accelerate US Market Expansion

The expansion includes furthering marketing efforts, driving cutting-edge new product research and development and strategically building a US-based team.

The institute is made up of a global network of life science experts and laboratories that provide customers with support for claim-substantiated cosmetics with biological mechanisms, biomarkers and preclinical or clinical capabilities.

Evonik Establishes the Evonik Skin Institute for Active Ingredients and Cosmetic Solutions

The institute is made up of a global network of life science experts and laboratories that provide customers with support for claim-substantiated cosmetics with biological mechanisms, biomarkers and preclinical or clinical capabilities.

Muhammed Majeed, Ph.D.

In Memory of Sami-Sabinsa Group's Founder: Muhammed Majeed, Ph.D.

Muhammed Majeed, Ph.D., founder and chairman of the Sami-Sabinsa Group, has sadly passed away following complications from surgery. His daughter, Anju Majeed, Ph.D., succeeds him as the company's chairperson.

One randomized controlled clinical study noted that Melasyl, known as 2-mercaptonicotinoyl glycine (2-MNG), 'prevents UV-induced skin darkening and delayed tanning in healthy subjects.'

The Science Behind L’Oréal's Melasyl Pigmentation Technology

Melasyl is a molecule designed to address localized pigmentation issues that lead to age spots and post-acne marks.

Patrick Charest, B. SC., P.Eng., CEO of Aplantex, said, 'It is with determination that the entire Aplantex team follows its game plan with discipline to become a leading supplier of high-value molecules to the pharmaceutical, cosmetics, and agri-food industries in the context of the international growth of the circular economy. We are encouraged to continue our tireless efforts by the significant support from leading private investors as well as government and institutional sources that contributed to the success of our second round of financing.'

Aplantex Secures $3.3M Round of Funding

The funding will be used to increase the production volume of the Boucherville research and production center to meet this anticipated demand.

Seppic Rgb Blue (4)

Seppic Unveils Redesigned Logo

The company sees the redesign as a way of redefining its brand platform, unveiling its ambitions, its vision and how the company wants to present itself.

Supergoop! CEO Lisa Sequino (left), pictured with founder Holly Thaggard.

Supergoop! Appoints Lisa Sequino CEO

Sequino most recently served as CEO of JLo Beauty following nearly two decades of experience driving growth in the beauty and personal care industry at Estee Lauder and Procter & Gamble.

Hårklinikken founder Lars Skjøth and CEO Stuart Millar.

Hårklinikken Appoints First CEO

This announcement comes as the company prepares for imminent expansion into new categories and geographical territories.

(from L): Bianca Brattoli and Adrianna Deremer, formulating chemists, Cosmetech Labs

Cosmetech Labs Celebrates 50 Years in the Industry

Founded in 1974 by David Garlen, Cosmetech Laboratories is celebrating 50 years as a full-service R&D laboratory serving the personal care, cosmetics and topical pharmaceutical industries.

Tosla 3 will serve as the company's hub for research and development, marketing and administrative operations.

Tosla Nutricosmetics Partners with Triiije Architects for Construction of Headquarters

Tosla 3 will serve as the company's hub for research and development, marketing and administrative operations.